Steven Cohen's FBLG Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 14,476 shares of FibroBiologics, Inc. (FBLG) worth $3,256, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Steven Cohen has initiated a new position in FBLG, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's FibroBiologics (FBLG) Holding Value Over Time
Track share changes against reported price movement
Quarterly FibroBiologics (FBLG) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +14,476 | New Buy | 14,476 | $0.22 |
Steven Cohen's FibroBiologics Investment FAQs
Steven Cohen first purchased FibroBiologics, Inc. (FBLG) in Q4 2025, acquiring 14,476 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held FibroBiologics, Inc. (FBLG) for 1 quarters since Q4 2025.
Steven Cohen's largest addition to FibroBiologics, Inc. (FBLG) was in Q4 2025, adding 14,476 shares worth $3,256.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 14,476 shares of FibroBiologics, Inc. (FBLG), valued at approximately $3,256.
As of the Q4 2025 filing, FibroBiologics, Inc. (FBLG) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in FibroBiologics, Inc. (FBLG) was 14,476 shares, as reported at the end of Q4 2025.